Header Logo

Connection

Alan Landay to Immunoglobulin G

This is a "connection" page, showing publications Alan Landay has written about Immunoglobulin G.
Connection Strength

1.153
  1. Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals. J Infect Dis. 2022 10 17; 226(8):1407-1411.
    View in: PubMed
    Score: 0.212
  2. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis. 2018 08 16; 67(5):770-777.
    View in: PubMed
    Score: 0.159
  3. Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy. J Leukoc Biol. 2018 09; 104(3):461-471.
    View in: PubMed
    Score: 0.155
  4. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women. AIDS Res Hum Retroviruses. 2016 Feb; 32(2):134-43.
    View in: PubMed
    Score: 0.130
  5. Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women. PLoS One. 2013; 8(4):e61973.
    View in: PubMed
    Score: 0.110
  6. Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis. 2012 Jun 15; 205(12):1788-96.
    View in: PubMed
    Score: 0.102
  7. Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time. Nat Commun. 2023 11 02; 14(1):7015.
    View in: PubMed
    Score: 0.057
  8. Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin G. J Infect Dis. 2022 Nov 28; 226(11):1934-1942.
    View in: PubMed
    Score: 0.053
  9. Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2. AIDS Res Hum Retroviruses. 2002 Jun 10; 18(9):661-5.
    View in: PubMed
    Score: 0.052
  10. Anti-CCR5 antibodies in sera of HIV-positive individuals. Hum Immunol. 2001 Feb; 62(2):143-5.
    View in: PubMed
    Score: 0.047
  11. Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy. PLoS One. 2017; 12(7):e0180245.
    View in: PubMed
    Score: 0.037
  12. Evaluation of human monocyte oxidative metabolism utilizing a flow cytometric assay. Clin Exp Immunol. 1989 Oct; 78(1):91-6.
    View in: PubMed
    Score: 0.021
  13. Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points. J Infect Dis. 1999 Apr; 179(4):799-807.
    View in: PubMed
    Score: 0.010
  14. Aggregated C-reactive protein binds to human polymorphonuclear leukocytes and potentiates Fc receptor-mediated chemiluminescence. J Lab Clin Med. 1986 Dec; 108(6):567-76.
    View in: PubMed
    Score: 0.004
  15. Enhancement of human peripheral blood monocyte respiratory burst activity by aggregated C-reactive protein. J Leukoc Biol. 1986 Dec; 40(6):769-83.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.